ResMed, based in San Diego, said it will integrate Medifox Dan’s capabilities into its out-of-hospital software-as-a-service business, expanding into such areas as outpatient therapy. ResMed currently offers digital health technology and devices to care for people with sleep apnea, chronic obstructive pulmonary disease and other chronic health conditions in the home.
“We are excited to welcome the Medifox Dan team to our global ResMed family: Our management cultures are highly aligned with a laser focus on lowering costs, improving outcomes, and changing the course of chronic disease management,” said ResMed CEO Mick Farrell in a June 14 company news release.
The deal is expected to close by Dec. 31.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
